Dr. Larry Cheskin

Vikesh Singh is a gastroenterologist who specializes in pancreatology and pancreaticobiliary endoscopy. He evaluates and treats patients with inflammatory diseases of the pancreas, including acute and chronic pancreatitis and autoimmune pancreatitis as well as the complications of these diseases. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Singh remained at Johns Hopkins to complete residency training in internal medicine. He pursued fellowship training in gastroenterology at Brigham and Women’s Hospital, and earned a master’s degree in epidemiology from the Harvard T. H. Chan School of Public Health. He then returned to Johns Hopkins, where he completed a two-year advanced endoscopy fellowship with a focus on pancreaticobiliary endoscopy. Dr. Singh has been on the faculty at Johns Hopkins since 2008, and rose to the rank of professor in 2021. His research interests include acute and chronic pancreatitis, autoimmune pancreatitis, exocrine pancreatic insufficiency, and novel methods to evaluate and treat abdominal pain. Dr. Singh is a member of the board of directors of the National Pancreas Foundation, chair of the Pancreatic Disorders Section of the American Gastroenterological Association, a councilor for the International Association of Pancreatology and a member of the inaugural medical advisory board for the Familial Chylomicronemia Syndrome Foundation. Dr. Singh is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Exocrine Pancreatic Insufficiency, Hereditary Pancreatitis, Acute Pancreatitis, Pancreatectomy, and Endoscopy. Dr. Singh is board certified in American Board Of Internal Medicine.

Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass. Dr. Khashab is board certified in American Board Of Internal Medicine.

"Michael Schweitzer, M.D., developed the laparoscopic bariatric surgery programs at the Medical College of Virginia (one of the first ten laparoscopic gastric bypass programs in the country), Georgetown University, Sinai Hospital of Baltimore and the Johns Hopkins University. Dr. Schweitzer was the first surgeon in the mid-Atlantic area to perform laparoscopic Roux-en-Y gastric bypass and the first in Maryland to perform laparoscopic adjustable gastric band surgery and laparoscopic duodenal switch with biliopancreatic diversion. Currently chair of the membership committee for the American Society of Bariatric Surgeons, Dr. Schweitzer also serves as a site inspector for the American College of Surgeons Bariatric Center of Excellence Program. He serves on three editorial boards: the Journal of Laparoendoscopic and Advanced Surgical Techniques, Surgery for Obesity and Related Diseases the official journal of the American Society of Bariatric Surgeons) and Bariatric Times. Dr. Schweitzer was the first to ever publish a technique for endoscopic stoma reduction using transoral endoscopic suturing. A great deal of attention is focused on the future of transoral surgery to avoid abdominal incisions for routine surgery (""No-Scar Surgery""). Dr. Schweitzer is one of the first to apply this technology to bariatric patients. A writer of numerous papers, chapters and review articles on bariatric surgery, several of Dr. Schweitzer''s laparoscopic bariatric surgical techniques have been featured in the American College of Surgeons Cine Video Series. He is considered an international expert on venous thromboembolic complications after bariatric surgery and has one of the lowest complication rates documented in world surgical literature. Dr. Schweitzer currently has an extremely active laparoscopic bariatric practice that includes laparoscopic Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, laparoscopic sleeve gastrectomy, laparoscopic duodenal switch with biliopancreatic diversion, and revision of previous surgery. The team at the Johns Hopkins Center for Bariatric Surgery has successfully completed over 2500 bariatric procedures.". Dr. Schweitzer is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Obesity, Hernia, Gastroesophageal Reflux Disease (GERD), Gastric Bypass, and Gastrectomy. Dr. Schweitzer is board certified in American Board Of Surgery.